시장보고서
상품코드
1420394

양식용 사료 및 의약품 시장 : 세계 업계 분석, 규모, 점유율, 성장, 동향, 예측(2031년) - 제품 유형별, 종류별, 지역별

Aquaculture Feed and Pharmaceutical Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region:

발행일: | 리서치사: Fairfield Market Research | 페이지 정보: 영문 202 Pages | 배송안내 : 2-5일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

세계의 양식용 사료 및 의약품 시장 규모는 2024년에는 9억 9,940만 달러에 달할 것으로 보이고 있습니다. 이 제품에 대한 수요는 세계에서 안정되어 있으며, 연간 평균 성장률(CAGR)은 7.4%로 예측됩니다. 그 결과, 시장은 2031년말에는 20억 달러에 달할 전망입니다.

세계의 양식용 사료 및 의약품 시장은 의약품 및 생물학적 제제 분야의 지속적인 발전과 연구로 인해 2031년까지 크게 성장할 준비가 되어 있습니다. 최근 시장 분석에 따르면 의약품 및 생물학적 제제 부문은 금액과 성장 측면에서 이 산업의 지배적인 세력으로 부상할 것이며, 생물학적 제제 하위 부문은 예측 기간 중 7.7%의 놀라운 CAGR을 기록하며 다른 부문을 압도할 것으로 예상됩니다.

다양한 제품 유형 중 의약품 및 생물학적 제제 부문은 시장 매력도 지수가 1.6으로 가장 유리한 부문입니다. 반면, 약용 사료 부문은 시장 매력도 지수 0.4로 가장 매력적이지 않을 것으로 예상됩니다.

세계의 양식용 사료 및 의약품 시장에 대해 조사했으며, 시장의 개요와 제품 유형별, 종류별, 지역별 동향 및 시장에 참여하는 기업의 경쟁 동향 등을 제공하고 있습니다.

목차

제1장 주요 요약

제2장 시장 개요

  • 시장의 정의와 세분화
  • 시장 역학
  • 밸류체인 분석
  • Porter's Five Forces 분석
  • COVID-19의 영향 분석
  • 우크라이나와 러시아의 분쟁의 영향
  • 경제 개요
  • PESTLE 분석

제3장 세계의 양식용 사료 및 의약품 시장 전망, 2018-2031년

  • 세계의 양식용 사료 및 의약품 시장 전망, 제품 유형별, 금액(10억 달러), 2018-2031년
  • 세계의 양식용 사료 및 의약품 시장 전망, 종류별, 금액(10억 달러), 2018-2031년
  • 세계의 양식용 사료 및 의약품 시장 전망, 지역별, 금액(10억 달러), 2018-2031년

제4장 북미의 양식용 사료 및 의약품 시장 전망, 2018-2031년

제5장 유럽의 양식용 사료 및 의약품 시장 전망, 2018-2031년

제6장 아시아태평양의 양식용 사료 및 의약품 시장 전망, 2018-2031년

제7장 라틴아메리카의 양식용 사료 및 의약품 시장 전망, 2018-2031년

제8장 중동 및 아프리카의 양식용 사료 및 의약품 시장 전망, 2018-2031년

제9장 경쟁 구도

  • 제품 유형별과 종류별 히트맵
  • 기업의 시장 점유율 분석, 2023년
  • 경쟁 대시보드
  • 기업 개요
    • Zoetis, Inc.
    • Schouw & Co
    • Ridley Corporation Ltd
    • Merck & Co Inc
    • Biomin Holding GmbH
    • Aller Aqua A/S
    • Nutriad Ltd.
    • Alltech Inc.
    • Avanti Feeds Ltd.
    • Norel S.A.
    • Cargill, Incorporated
    • Beneo GmbH
    • Skretting AS

제10장 부록

KSA 24.02.14

The global market size for aquaculture feed and pharmaceuticals is currently estimated to be at US$ 999.4 million in 2024. It is anticipated that there will be a steady demand for these products worldwide, with a projected Compound Annual Growth Rate (CAGR) of 7.4%. As a result, the market is expected to reach a valuation of US$ 2 billion by the conclusion of 2031.

The global aquaculture feed and pharmaceuticals market is poised for significant growth through 2031, driven by continuous advancements and research in the field of pharmaceuticals and biologics. A recent market analysis indicates that the pharmaceutical and biologics segment will emerge as the dominant force in this industry, both in terms of value and growth with the biologics sub-segment expected to outperform others, boasting an impressive 7.7% compound annual growth rate (CAGR) during the forecast period.

Most Lucrative Segment with Strong Market Attractiveness

Among various product types, the pharmaceutical and biologics segment is set to be the most lucrative, boasting a market attractiveness index of 1.6. In contrast, the medicated feed segment is expected to be the least attractive, with a market attractiveness index of 0.4.

Driving Factors Behind Market Growth

Several factors are fueling the growth of the pharmaceutical and biologics segment in the aquaculture feed and pharmaceuticals market. There is a growing demand for structured research and development in the aquaculture field, particularly in biologics research. This has led to a faster introduction of drugs, medicated feed, and vaccines into regional markets, particularly in developed countries such as the United States and Canada. Such initiatives have stimulated inorganic growth through strategic partnerships and M&A activities among key industry players.

Key Trends and Developments

In the United States, the use of extra label drugs in aquaculture, under the guidance of licensed veterinarians, has opened up opportunities for the development of medicated feed and pharmaceuticals. Regulatory bodies, such as the FDA, support the use of approved extra label aquaculture medicated feeds, provided they meet compliance conditions. This development is expected to expand the scope for further advancements in medicated feed and pharmaceuticals for aquaculture.

Furthermore, the demand for in-feed medication as a prophylactic measure is on the rise in the global aquaculture feed and pharmaceutical market. The adoption of in-feed medication to prevent the spread of diseases among healthy fish is growing, particularly in organized fishing farms across Europe. This trend aligns with the limited use of antibiotics in the region.

Governmental Collaborations Drive R&D

Governments in various countries are initiating collaborative research and development efforts in partnership with regulatory bodies to enhance the availability of high-quality medicated feed and pharmaceuticals for aquaculture. As aquaculture becomes a crucial source of food for human consumption, the need for safe and effective treatments for various fish diseases has grown significantly.

Challenges Ahead

Despite the growth prospects, the lack of harmonization of veterinary medicinal products and medicated feed regulations across different regions, particularly in the European Union, poses challenges. Different laws for manufacturing veterinary medicines and medicated feed, along with varying residue limits of veterinary medicines in feed, hinder market estimation and forecasting efforts.

Competitive Analysis:

Some of the prominent players in the global market for aquaculture feed & pharmaceutical market are:

  • Zoetis, Inc.
  • Schouw & Co
  • Ridley Corporation Ltd
  • Merck & Co Inc
  • Biomin Holding GmbH
  • Aller Aqua A/S
  • Nutriad Ltd.
  • Alltech Inc.
  • Avanti Feeds Ltd.
  • Norel S.A.
  • Cargill, Incorporated
  • Beneo GmbH
  • Skretting AS
  • Novus International Inc.
  • Growel Feeds Pvt. Ltd.
  • Neovia Vietnam
  • Evonik Industries AG
  • Bayer AG
  • Koninklijke DSM N.V
  • Others.

Market Segmentation

Product Type

  • Pharmaceutical and Biologics

Anti-infectives

Parasiticides

Biologics

Others

  • Medicated Feed

Vitamins and Minerals

Amino Acids

Acidifiers

Others

Species

  • Molluscs
  • Shrimp
  • Salmons
  • Carps
  • Tilapia
  • Catfish
  • Others

Region

  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • Middle East and Africa (MEA)

Table of Contents

1. Executive Summary

  • 1.1. Global Aquaculture Feed and Pharmaceutical Market Snapshot
  • 1.2. Future Projections
  • 1.3. Key Market Trends
  • 1.4. Regional Snapshot, by Value, 2023
  • 1.5. Analyst Recommendations

2. Market Overview

  • 2.1. Market Definitions and Segmentations
  • 2.2. Market Dynamics
    • 2.2.1. Drivers
    • 2.2.2. Restraints
    • 2.2.3. Market Opportunities
  • 2.3. Value Chain Analysis
  • 2.4. Porter's Five Forces Analysis
  • 2.5. COVID-19 Impact Analysis
    • 2.5.1. Supply
    • 2.5.2. Demand
  • 2.6. Impact of Ukraine-Russia Conflict
  • 2.7. Economic Overview
    • 2.7.1. World Economic Projections
  • 2.8. PESTLE Analysis

3. Global Aquaculture Feed and Pharmaceutical Market Outlook, 2018 - 2031

  • 3.1. Global Aquaculture Feed and Pharmaceutical Market Outlook, by Product Type, Value (US$ Bn), 2018 - 2031
    • 3.1.1. Key Highlights
      • 3.1.1.1. Pharmaceutical and Biologics
        • 3.1.1.1.1. Anti-infectives
        • 3.1.1.1.2. Parasiticides
        • 3.1.1.1.3. Biologics
        • 3.1.1.1.4. Others
      • 3.1.1.2. Medicated Feed
        • 3.1.1.2.1. Vitamins and Minerals
        • 3.1.1.2.2. Amino Acids
        • 3.1.1.2.3. Acidifiers
        • 3.1.1.2.4. Others
  • 3.2. Global Aquaculture Feed and Pharmaceutical Market Outlook, by Species, Value (US$ Bn), 2018 - 2031
    • 3.2.1. Key Highlights
      • 3.2.1.1. Molluscs
      • 3.2.1.2. Shrimp
      • 3.2.1.3. Salmons
      • 3.2.1.4. Carps
      • 3.2.1.5. Tilapia
      • 3.2.1.6. Catfish
      • 3.2.1.7. Others
  • 3.3. Global Aquaculture Feed and Pharmaceutical Market Outlook, by Region, Value (US$ Bn), 2018 - 2031
    • 3.3.1. Key Highlights
      • 3.3.1.1. North America
      • 3.3.1.2. Europe
      • 3.3.1.3. Asia Pacific
      • 3.3.1.4. Latin America
      • 3.3.1.5. Middle East & Africa

4. North America Aquaculture Feed and Pharmaceutical Market Outlook, 2018 - 2031

  • 4.1. North America Aquaculture Feed and Pharmaceutical Market Outlook, by Product Type, Value (US$ Bn), 2018 - 2031
    • 4.1.1. Key Highlights
      • 4.1.1.1. Pharmaceutical and Biologics
        • 4.1.1.1.1. Anti-infectives
        • 4.1.1.1.2. Parasiticides
        • 4.1.1.1.3. Biologics
        • 4.1.1.1.4. Others
      • 4.1.1.2. Medicated Feed
        • 4.1.1.2.1. Vitamins and Minerals
        • 4.1.1.2.2. Amino Acids
        • 4.1.1.2.3. Acidifiers
        • 4.1.1.2.4. Others
  • 4.2. North America Aquaculture Feed and Pharmaceutical Market Outlook, by Species, Value (US$ Bn), 2018 - 2031
    • 4.2.1. Key Highlights
      • 4.2.1.1. Molluscs
      • 4.2.1.2. Shrimp
      • 4.2.1.3. Salmons
      • 4.2.1.4. Carps
      • 4.2.1.5. Tilapia
      • 4.2.1.6. Catfish
      • 4.2.1.7. Others
    • 4.2.2. BPS Analysis/Market Attractiveness Analysis
  • 4.3. North America Aquaculture Feed and Pharmaceutical Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
    • 4.3.1. Key Highlights
      • 4.3.1.1. U.S. Aquaculture Feed and Pharmaceutical Market by Product Type, Value (US$ Bn), 2018 - 2031
      • 4.3.1.2. U.S. Aquaculture Feed and Pharmaceutical Market by Species, Value (US$ Bn), 2018 - 2031
      • 4.3.1.3. Canada Aquaculture Feed and Pharmaceutical Market by Product Type, Value (US$ Bn), 2018 - 2031
      • 4.3.1.4. Canada Aquaculture Feed and Pharmaceutical Market by Species, Value (US$ Bn), 2018 - 2031
    • 4.3.2. BPS Analysis/Market Attractiveness Analysis

5. Europe Aquaculture Feed and Pharmaceutical Market Outlook, 2018 - 2031

  • 5.1. Europe Aquaculture Feed and Pharmaceutical Market Outlook, by Product Type, Value (US$ Bn), 2018 - 2031
    • 5.1.1. Key Highlights
      • 5.1.1.1. Pharmaceutical and Biologics
        • 5.1.1.1.1. Anti-infectives
        • 5.1.1.1.2. Parasiticides
        • 5.1.1.1.3. Biologics
        • 5.1.1.1.4. Others
      • 5.1.1.2. Medicated Feed
        • 5.1.1.2.1. Vitamins and Minerals
        • 5.1.1.2.2. Amino Acids
        • 5.1.1.2.3. Acidifiers
        • 5.1.1.2.4. Others
  • 5.2. Europe Aquaculture Feed and Pharmaceutical Market Outlook, by Species, Value (US$ Bn), 2018 - 2031
    • 5.2.1. Key Highlights
      • 5.2.1.1. Molluscs
      • 5.2.1.2. Shrimp
      • 5.2.1.3. Salmons
      • 5.2.1.4. Carps
      • 5.2.1.5. Tilapia
      • 5.2.1.6. Catfish
      • 5.2.1.7. Others
    • 5.2.2. BPS Analysis/Market Attractiveness Analysis
  • 5.3. Europe Aquaculture Feed and Pharmaceutical Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
    • 5.3.1. Key Highlights
      • 5.3.1.1. Germany Aquaculture Feed and Pharmaceutical Market by Product Type, Value (US$ Bn), 2018 - 2031
      • 5.3.1.2. Germany Aquaculture Feed and Pharmaceutical Market by Species, Value (US$ Bn), 2018 - 2031
      • 5.3.1.3. U.K. Aquaculture Feed and Pharmaceutical Market by Product Type, Value (US$ Bn), 2018 - 2031
      • 5.3.1.4. U.K. Aquaculture Feed and Pharmaceutical Market by Species, Value (US$ Bn), 2018 - 2031
      • 5.3.1.5. France Aquaculture Feed and Pharmaceutical Market by Product Type, Value (US$ Bn), 2018 - 2031
      • 5.3.1.6. France Aquaculture Feed and Pharmaceutical Market by Species, Value (US$ Bn), 2018 - 2031
      • 5.3.1.7. Italy Aquaculture Feed and Pharmaceutical Market by Product Type, Value (US$ Bn), 2018 - 2031
      • 5.3.1.8. Italy Aquaculture Feed and Pharmaceutical Market by Species, Value (US$ Bn), 2018 - 2031
      • 5.3.1.9. Turkey Aquaculture Feed and Pharmaceutical Market by Product Type, Value (US$ Bn), 2018 - 2031
      • 5.3.1.10. Turkey Aquaculture Feed and Pharmaceutical Market by Species, Value (US$ Bn), 2018 - 2031
      • 5.3.1.11. Russia Aquaculture Feed and Pharmaceutical Market by Product Type, Value (US$ Bn), 2018 - 2031
      • 5.3.1.12. Russia Aquaculture Feed and Pharmaceutical Market by Species, Value (US$ Bn), 2018 - 2031
      • 5.3.1.13. Rest of Europe Aquaculture Feed and Pharmaceutical Market by Product Type, Value (US$ Bn), 2018 - 2031
      • 5.3.1.14. Rest of Europe Aquaculture Feed and Pharmaceutical Market by Species, Value (US$ Bn), 2018 - 2031
    • 5.3.2. BPS Analysis/Market Attractiveness Analysis

6. Asia Pacific Aquaculture Feed and Pharmaceutical Market Outlook, 2018 - 2031

  • 6.1. Asia Pacific Aquaculture Feed and Pharmaceutical Market Outlook, by Product Type, Value (US$ Bn), 2018 - 2031
    • 6.1.1. Key Highlights
      • 6.1.1.1. Pharmaceutical and Biologics
        • 6.1.1.1.1. Anti-infectives
        • 6.1.1.1.2. Parasiticides
        • 6.1.1.1.3. Biologics
        • 6.1.1.1.4. Others
      • 6.1.1.2. Medicated Feed
        • 6.1.1.2.1. Vitamins and Minerals
        • 6.1.1.2.2. Amino Acids
        • 6.1.1.2.3. Acidifiers
        • 6.1.1.2.4. Others
  • 6.2. Asia Pacific Aquaculture Feed and Pharmaceutical Market Outlook, by Species, Value (US$ Bn), 2018 - 2031
    • 6.2.1. Key Highlights
      • 6.2.1.1. Molluscs
      • 6.2.1.2. Shrimp
      • 6.2.1.3. Salmons
      • 6.2.1.4. Carps
      • 6.2.1.5. Tilapia
      • 6.2.1.6. Catfish
      • 6.2.1.7. Others
    • 6.2.2. Others BPS Analysis/Market Attractiveness Analysis
  • 6.3. Asia Pacific Aquaculture Feed and Pharmaceutical Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
    • 6.3.1. Key Highlights
      • 6.3.1.1. China Aquaculture Feed and Pharmaceutical Market by Product Type, Value (US$ Bn), 2018 - 2031
      • 6.3.1.2. China Aquaculture Feed and Pharmaceutical Market by Species, Value (US$ Bn), 2018 - 2031
      • 6.3.1.3. Japan Aquaculture Feed and Pharmaceutical Market by Product Type, Value (US$ Bn), 2018 - 2031
      • 6.3.1.4. Japan Aquaculture Feed and Pharmaceutical Market by Species, Value (US$ Bn), 2018 - 2031
      • 6.3.1.5. South Korea Aquaculture Feed and Pharmaceutical Market by Product Type, Value (US$ Bn), 2018 - 2031
      • 6.3.1.6. South Korea Aquaculture Feed and Pharmaceutical Market by Species, Value (US$ Bn), 2018 - 2031
      • 6.3.1.7. India Aquaculture Feed and Pharmaceutical Market by Product Type, Value (US$ Bn), 2018 - 2031
      • 6.3.1.8. India Aquaculture Feed and Pharmaceutical Market by Species, Value (US$ Bn), 2018 - 2031
      • 6.3.1.9. Southeast Asia Aquaculture Feed and Pharmaceutical Market by Product Type, Value (US$ Bn), 2018 - 2031
      • 6.3.1.10. Southeast Asia Aquaculture Feed and Pharmaceutical Market by Species, Value (US$ Bn), 2018 - 2031
      • 6.3.1.11. Rest of Asia Pacific Aquaculture Feed and Pharmaceutical Market by Product Type, Value (US$ Bn), 2018 - 2031
      • 6.3.1.12. Rest of Asia Pacific Aquaculture Feed and Pharmaceutical Market by Species, Value (US$ Bn), 2018 - 2031
    • 6.3.2. BPS Analysis/Market Attractiveness Analysis

7. Latin America Aquaculture Feed and Pharmaceutical Market Outlook, 2018 - 2031

  • 7.1. Latin America Aquaculture Feed and Pharmaceutical Market Outlook, by Product Type, Value (US$ Bn), 2018 - 2031
    • 7.1.1. Key Highlights
      • 7.1.1.1. Pharmaceutical and Biologics
        • 7.1.1.1.1. Anti-infectives
        • 7.1.1.1.2. Parasiticides
        • 7.1.1.1.3. Biologics
        • 7.1.1.1.4. Others
      • 7.1.1.2. Medicated Feed
        • 7.1.1.2.1. Vitamins and Minerals
        • 7.1.1.2.2. Amino Acids
        • 7.1.1.2.3. Acidifiers
        • 7.1.1.2.4. Others
  • 7.2. Latin America Aquaculture Feed and Pharmaceutical Market Outlook, by Species, Value (US$ Bn), 2018 - 2031
    • 7.2.1. Key Highlights
      • 7.2.1.1. Molluscs
      • 7.2.1.2. Shrimp
      • 7.2.1.3. Salmons
      • 7.2.1.4. Carps
      • 7.2.1.5. Tilapia
      • 7.2.1.6. Catfish
      • 7.2.1.7. Others
    • 7.2.2. BPS Analysis/Market Attractiveness Analysis
  • 7.3. Latin America Aquaculture Feed and Pharmaceutical Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
    • 7.3.1. Key Highlights
      • 7.3.1.1. Brazil Aquaculture Feed and Pharmaceutical Market by Product Type, Value (US$ Bn), 2018 - 2031
      • 7.3.1.2. Brazil Aquaculture Feed and Pharmaceutical Market by Species, Value (US$ Bn), 2018 - 2031
      • 7.3.1.3. Mexico Aquaculture Feed and Pharmaceutical Market by Product Type, Value (US$ Bn), 2018 - 2031
      • 7.3.1.4. Mexico Aquaculture Feed and Pharmaceutical Market by Species, Value (US$ Bn), 2018 - 2031
      • 7.3.1.5. Argentina Aquaculture Feed and Pharmaceutical Market by Product Type, Value (US$ Bn), 2018 - 2031
      • 7.3.1.6. Argentina Aquaculture Feed and Pharmaceutical Market by Species, Value (US$ Bn), 2018 - 2031
      • 7.3.1.7. Rest of Latin America Aquaculture Feed and Pharmaceutical Market by Product Type, Value (US$ Bn), 2018 - 2031
      • 7.3.1.8. Rest of Latin America Aquaculture Feed and Pharmaceutical Market by Species, Value (US$ Bn), 2018 - 2031
    • 7.3.2. BPS Analysis/Market Attractiveness Analysis

8. Middle East & Africa Aquaculture Feed and Pharmaceutical Market Outlook, 2018 - 2031

  • 8.1. Middle East & Africa Aquaculture Feed and Pharmaceutical Market Outlook, by Product Type, Value (US$ Bn), 2018 - 2031
    • 8.1.1. Key Highlights
      • 8.1.1.1. Pharmaceutical and Biologics
        • 8.1.1.1.1. Anti-infectives
        • 8.1.1.1.2. Parasiticides
        • 8.1.1.1.3. Biologics
        • 8.1.1.1.4. Others
      • 8.1.1.2. Medicated Feed
        • 8.1.1.2.1. Vitamins and Minerals
        • 8.1.1.2.2. Amino Acids
        • 8.1.1.2.3. Acidifiers
        • 8.1.1.2.4. Others
  • 8.2. Middle East & Africa Aquaculture Feed and Pharmaceutical Market Outlook, by Species, Value (US$ Bn), 2018 - 2031
    • 8.2.1. Key Highlights
      • 8.2.1.1. Molluscs
      • 8.2.1.2. Shrimp
      • 8.2.1.3. Salmons
      • 8.2.1.4. Carps
      • 8.2.1.5. Tilapia
      • 8.2.1.6. Catfish
      • 8.2.1.7. Others
    • 8.2.2. BPS Analysis/Market Attractiveness Analysis
  • 8.3. Middle East & Africa Aquaculture Feed and Pharmaceutical Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
    • 8.3.1. Key Highlights
      • 8.3.1.1. GCC Aquaculture Feed and Pharmaceutical Market by Product Type, Value (US$ Bn), 2018 - 2031
      • 8.3.1.2. GCC Aquaculture Feed and Pharmaceutical Market by Species, Value (US$ Bn), 2018 - 2031
      • 8.3.1.3. South Africa Aquaculture Feed and Pharmaceutical Market by Product Type, Value (US$ Bn), 2018 - 2031
      • 8.3.1.4. South Africa Aquaculture Feed and Pharmaceutical Market by Species, Value (US$ Bn), 2018 - 2031
      • 8.3.1.5. Egypt Aquaculture Feed and Pharmaceutical Market by Product Type, Value (US$ Bn), 2018 - 2031
      • 8.3.1.6. Egypt Aquaculture Feed and Pharmaceutical Market by Species, Value (US$ Bn), 2018 - 2031
      • 8.3.1.7. Nigeria Aquaculture Feed and Pharmaceutical Market by Product Type, Value (US$ Bn), 2018 - 2031
      • 8.3.1.8. Nigeria Aquaculture Feed and Pharmaceutical Market by Species, Value (US$ Bn), 2018 - 2031
      • 8.3.1.9. Rest of Middle East & Africa Aquaculture Feed and Pharmaceutical Market by Product Type, Value (US$ Bn), 2018 - 2031
      • 8.3.1.10. Rest of Middle East & Africa Aquaculture Feed and Pharmaceutical Market by Species, Value (US$ Bn), 2018 - 2031
    • 8.3.2. BPS Analysis/Market Attractiveness Analysis

9. Competitive Landscape

  • 9.1. Product Type vs by Species Heatmap
  • 9.2. Company Market Share Analysis, 2023
  • 9.3. Competitive Dashboard
  • 9.4. Company Profiles
    • 9.4.1. Zoetis, Inc.
      • 9.4.1.1. Company Overview
      • 9.4.1.2. Product Portfolio
      • 9.4.1.3. Financial Overview
      • 9.4.1.4. Business Strategies and Development
    • 9.4.2. Schouw & Co
      • 9.4.2.1. Company Overview
      • 9.4.2.2. Product Portfolio
      • 9.4.2.3. Financial Overview
      • 9.4.2.4. Business Strategies and Development
    • 9.4.3. Ridley Corporation Ltd
      • 9.4.3.1. Company Overview
      • 9.4.3.2. Product Portfolio
      • 9.4.3.3. Financial Overview
      • 9.4.3.4. Business Strategies and Development
    • 9.4.4. Merck & Co Inc
      • 9.4.4.1. Company Overview
      • 9.4.4.2. Product Portfolio
      • 9.4.4.3. Financial Overview
      • 9.4.4.4. Business Strategies and Development
    • 9.4.5. Biomin Holding GmbH
      • 9.4.5.1. Company Overview
      • 9.4.5.2. Product Portfolio
      • 9.4.5.3. Financial Overview
      • 9.4.5.4. Business Strategies and Development
    • 9.4.6. Aller Aqua A/S
      • 9.4.6.1. Company Overview
      • 9.4.6.2. Product Portfolio
      • 9.4.6.3. Financial Overview
      • 9.4.6.4. Business Strategies and Development
    • 9.4.7. Nutriad Ltd.
      • 9.4.7.1. Company Overview
      • 9.4.7.2. Product Portfolio
      • 9.4.7.3. Financial Overview
      • 9.4.7.4. Business Strategies and Development
    • 9.4.8. Alltech Inc.
      • 9.4.8.1. Company Overview
      • 9.4.8.2. Product Portfolio
      • 9.4.8.3. Financial Overview
      • 9.4.8.4. Business Strategies and Development
    • 9.4.9. Avanti Feeds Ltd.
      • 9.4.9.1. Company Overview
      • 9.4.9.2. Product Portfolio
      • 9.4.9.3. Financial Overview
      • 9.4.9.4. Business Strategies and Development
    • 9.4.10. Norel S.A.
      • 9.4.10.1. Company Overview
      • 9.4.10.2. Product Portfolio
      • 9.4.10.3. Financial Overview
      • 9.4.10.4. Business Strategies and Development
    • 9.4.11. Cargill, Incorporated
      • 9.4.11.1. Company Overview
      • 9.4.11.2. Product Portfolio
      • 9.4.11.3. Financial Overview
      • 9.4.11.4. Business Strategies and Development
    • 9.4.12. Beneo GmbH
      • 9.4.12.1. Company Overview
      • 9.4.12.2. Product Portfolio
      • 9.4.12.3. Financial Overview
      • 9.4.12.4. Business Strategies and Development
    • 9.4.13. Skretting AS
      • 9.4.13.1. Company Overview
      • 9.4.13.2. Product Portfolio
      • 9.4.13.3. Financial Overview
      • 9.4.13.4. Business Strategies and Development

10. Appendix

  • 10.1. Research Methodology
  • 10.2. Report Assumptions
  • 10.3. Acronyms and Abbreviations
샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제